LILRB4 Expression in Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome Based on Response to Hypomethylating Agents

LILRB4 is expressed on AML M4/M5 cells and negatively regulates immune cell activation via T cell suppression. Its expression and role in CMML and MDS are unknown. We investigated LILRB4 expression in 19 CMML and 27 MDS patients and correlated it with response to subsequent HMA therapy. LILRB4 RNA e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Lymphoma
Main Authors: Chien, Kelly S., Class, Caleb A., Montalban-Bravo, Guillermo, Wei, Yue, Sasaki, Koji, Naqvi, Kiran, Ganan-Gomez, Irene, Yang, Hui, Soltysiak, Kelly A., Kanagal-Shamanna, Rashmi, Do, Kim-Anh, Kantarjian, Hagop M., Garcia-Manero, Guillermo
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836710/
https://ncbi.nlm.nih.gov/pubmed/32036728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2020.1723014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados